+198,914.9%
LRCX vs EMR
+4,267.5%
+194,647.4%
-87.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.7% | -3.4% | -3.2% | -4.2% |
| 7D | -4.7% | -4.9% | +0.2% | -1.2% |
| 30D | -20.1% | -0.2% | -20.0% | -19.4% |
| 3M | -36.5% | -1.2% | -35.3% | -35.3% |
| 6M | -25.8% | +21.6% | -47.4% | -34.1% |
| YTD | +23.5% | +22.9% | +0.7% | +8.7% |
| 1Y | +42.9% | +27.8% | +15.1% | +22.5% |
| 3Y | +208.6% | +93.1% | +115.5% | +100.5% |
| 5Y | +249.7% | +84.0% | +165.7% | +136.3% |
| 10Y | +2,279.2% | +270.9% | +2,008.3% | +869.2% |
| All | +198,914.9% | +4,267.5% | +194,647.4% | +16,176.1% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling